LI
KDNY

LMCG Investments’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

LMCG Investments’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$4.73M Buy
48,876
+15,494
+46% +$1.85M 0.1% 308
2015
Q2 		$5.06M Buy
+33,382
New +$5.51M 0.11% 297

Other funds holding KDNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
M&T Bank
M&T Bank Buffalo, New York $29.2B AUM 22.81% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

LMCG Investments's KDNY Position: Q3 2015 in Review

LMCG Investments increased its Chinook Therapeutics, Inc. Common Stock (KDNY) stake by 46% in Q3 2015, buying an estimated $1.85M and bringing the position to 48,876 shares worth $4.73M. The position accounts for 0.1% of the portfolio, ranked #308.

LMCG Investments first reported a position in KDNY in Q2 2015 and has held it in 2 quarters since. The position peaked at $5.06M in Q2 2015. 76 funds tracked by Wall St. Rank hold KDNY as of Q3 2015.

  • LMCG Investments held 48,876 shares of Chinook Therapeutics, Inc. Common Stock worth $4.73M as of Q3 2015.
  • LMCG Investments bought 15,494 Chinook Therapeutics, Inc. Common Stock shares in Q3 2015, an estimated $1.85M.
  • Chinook Therapeutics, Inc. Common Stock made up 0.1% of LMCG Investments's portfolio in Q3 2015, its #308 holding.
  • LMCG Investments first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and has held it in 2 quarters since.
  • LMCG Investments's Chinook Therapeutics, Inc. Common Stock position peaked at $5.06M in Q2 2015.
  • 76 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2015.

Based on LMCG Investments's 13F filing for Q3 2015, filed 4 Nov 2015.